Progress in interventional mechanism of paeoniflorin on Alzheimer’s disease
10.7501/j.issn.0253-2670.2019.04.034
- Author:
Min XING
1
Author Information
1. Academy of Integrated Chinese and Western Medicine, Fujian University of Traditional Chinese Medicine
- Publication Type:Journal Article
- Keywords:
Alzheimer’s disease;
Amyloid β-protein;
Chinese materia medica monomer;
Paeoniflorin;
Tau protein
- From:
Chinese Traditional and Herbal Drugs
2019;50(4):1022-1026
- CountryChina
- Language:Chinese
-
Abstract:
Alzheimer’s disease (AD) is one of the main pathogenies of the cognitive decline in aging population. Paeoniflorin is a water-soluble monoterpene isolated from the roots of Paeonia lactiflora or P. suffruticosa, which are both in the family Ranunculaceae. Paeoniflorin has the effect of improving the cognitive ability, sedative, anti-inflammatory, analgesic, and spasmolytisch activities. It could also regulate hyperphosphorylation of Tau and Aβ proteins; Paeoniflorin can restore the balance of neurotransmitter and neurotransmitter receptors including acetylcholine, nerve growth factor, calcium ion, α7 nicotinic acetylcholine receptor and adenosine receptors, and reduce inflammation, oxidative stress and neuron apoptosis in AD animal and cell models. This paper reviewed relevant research in the past decade about the effect of paeoniflorin on AD, which may provide theoretical basis to use agent from Chinese medicine for AD prevention and treatment.
